Fibromyalgia (FM) syndrome is characterized by pain and widespread hyperalgesia to mechanical, thermal, and electrical stimuli. Despite convincing evidence for central sensitization of nociceptive pain pathways, the role of peripheral tissue impulse input in the initiation and maintenance of FM is unclear. Therefore this randomized, double-blind, placebo-controlled trial of 22 female normal controls (NCs) and 28 female FM subjects tested the effects of trapezius muscle (TrapM) tender point injections with 1% lidocaine on local pain thresholds as well as on remote heat hyperalgesia at the forearm. Prior to muscle injections shoulder pain was standardized by tonic mechanical muscle stimulation, resulting in local pain ratings of 4.0 ± 0.5 VAS units. Tonic muscle stimulation was interrupted for the TrapM injections but was continued afterwards at the same level. NC as well as FM subjects experienced significant increases of TrapM pressure pain thresholds from lidocaine injections but not from placebo injections (p < 0.001). Additionally, heat hyperalgesia of FM participants was significantly reduced at areas remote from the injection site (forearm) by lidocaine but not by placebo (p = 0.02). Neither lidocaine nor saline injections significantly affected clinical FM pain ratings, a result most likely due to the very low dose of lidocaine (50 mg) used in this trial. Conclusion: Lidocaine injections increased local pain thresholds and decreased remote secondary heat hyperalgesia in FM patients, emphasizing the important role of peripheral impulse input in maintaining central sensitization in this chronic pain syndrome; similar to other persistent pain conditions such as irritable bowel syndrome and complex regional pain syndrome. Ó
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Introduction
Fibromyalgia (FM) is a chronic pain syndrome that is defined by the presence of mechanical hyperalgesia and widespread pain, consistently felt in deep tissues [54] . It is related to central sensitization [8,33] which may result from both peripheral and central mechanisms. Although several psychophysical and brain imaging studies provided support for central sensitization in FM [13,26,37-40,45,46,53], less evidence exists for abnormalities of peripheral painful tissues and associated primary afferent neurons. Several FM studies not only described various abnormalities that could be associated with sensitization of deep tissue nociceptors [4-6,10,19,27] but also reported associations of overall clinical pain intensity with the number of painful body areas [42] and ratings of local pains [48] . Thus, it is quite conceivable that pathophysiological changes in deep tissues of FM patients may result in increased responsiveness of neurons innervating these tissues, thereby providing tonic impulse input to the central nervous system. This input could induce and maintain central sensitization.
Ongoing afferent input from peripheral sources is known to dynamically maintain central sensitization and account for spontaneous pain, hyperalgesia, and allodynia [12, 28, 31] . Peripheral anesthetic blockade of critical somatic foci in complex regional pain syndrome (CRPS) effectively abolished both spontaneous and elicited pains as well as cold/mechano-allodynia within multiple body regions, including regions remotely distant from these critical foci [12] . A similar reversal occurred with sympathetic blocks in some CRPS patients [28, 31] . Similarly, the role of tonic impulse input for somatic pain has been tested in irritable bowel syndrome (IBS) patients by rectal administration of lidocaine gel [50] . This treatment normalized secondary heat hyperalgesia at the lower extremities of IBS patients who could not subjectively distinguish the lidocaine condition from the placebo condition [50] . Importantly, these effects were not accompanied by systemic absorption of lidocaine because blood levels were below the limit of detection [50] .
